people die every year from drug-resistant infections. Without urgent action, this number is projected to increase exponentially. By investing in research and development for new treatments, for everyone who needs them, we can save lives.
dollars are lost annually due to hospital-acquired infections in the US and Europe. Drug resistance is making these infections harder to treat. In turn, surgical procedures and cancer treatment carry greater risk. New antibiotics are needed to protect our healthcare systems.
The discovery of antibiotics transformed our world by making previously incurable illnesses treatable and allowing medical procedures like operations and chemotherapy to be performed safely. Millions of lives have been saved and our well-being radically improved. But our time with these drugs is running out. Antibiotics have been used so extensively many infections are once more untreatable.
Drug-resistant bacteria can infect anyone, of any age, in any country. It’s why antibiotic resistance is one of the biggest threats to global health. We can’t afford to wait.
We need to fund the research and development of new antibiotics today. And ensure access to these treatments for everyone who needs them, wherever they live.
Millions of people worldwide contract infections from harmful bacteria and are increasingly dying due to the lack of effective antibiotics. Your donation will support the research and development of urgently needed antibiotics, and access to these treatments for all who need them.
Health is a powerful driver of productivity, social stability and economic growth. Everyone’s health is dependent on effective antibiotics. Investing in the research and development of new treatments is good value for money that helps build a more prosperous future.
Drug-resistant bacterial infections can infect anyone, of any age, in any country. But it is our most vulnerable who are hit first and hardest. You can support the research and development of antibiotics to protect those most at risk: newborns, people with weakened immune systems, those in hospitals requiring medical procedures, and the elderly.
“We were already facing an uphill battle with COVID-19. Not only were patients battling with the virus, they then had to face a secondary infection on top of it, which could often not be treated because of antibiotic resistance.”
For South African doctor Chelsea Kruger, working in a COVID-19 ward at the height of the first wave of the pandemic was compounded with the frightening reality of an outbreak of antibiotic-resistant bacterial infections.
Chelsea Kruger, medical doctor and researcher
Learn why there is a drug resistance crisis, why so few new antibiotics have been developed and how you can support GARDP in our mission to ensure everyone who needs antibiotics receives effective treatments, no matter where they live.Download DOCUMENT now